How much Mark Cuban's $33 million in 'Shark Tank' investments earned him
How much Mark Cuban's $33 million in 'Shark Tank' investments earned him
Show Caption
Hide Caption
Watch Mark Cuban's 'Shark Tank' farewell in final episode
The sharks got emotional bidding Mark Cuban farewell on the maverick star's final appearance after 14 years on "Shark Tank."
Mark Cuban has made gains and setbacks during his time on "Shark Tank."
After 15 seasons on the hit ABC business reality show, Cuban, 66, appeared in his final "Shark Tank" episode May 16, during the Season 16 finale.
The savvy Dallas Mavericks minority owner, along with his fellow sharks, has made a few bad bets while investing on the show, though ultimately, he said he's turned a major profit.
Cuban told CNBC Make It that he invested "about $33 million" during his time on the show, receiving $35 million in cash returns and holding equity now worth "at least $250 million."
The businessman has invested in dozens of "Shark Tank" featured businesses over the years, and committed to even more on screen. One business in particular had all five sharks – Cuban, Kevin O'Leary, Daymond John, Lori Greiner and Robert Herjavec – biting for the first time. All pooled a $1 million investment for a 30% company stake, which turned out to be a dud.
Why Mark Cuban is leaving 'Shark Tank,' and his worst TV investment ever
In 2013, entrepreneur Charles Michael Yim pitched his Breathometer as the world's first smartphone breathalyzer. Yim even brought champagne to test it. Blame the bubbles, but the pitch worked.
The party started to end in January 2017, when the Federal Trade Commission filed a complaint against Yim and Breathometer, alleging the company misled customers about the product's ability to accurately measure blood alcohol content.
Breathometer settled with the FTC over that complaint, but was compelled to fully refund every customer who had purchased the device (typically retailing for $49.99), according to an FTC statement.
"It was a lot of money, and I did a poor job of due diligence," Cuban told USA TODAY. "It really didn't turn out anywhere near what I expected."
Cuban has also made several impressive deals, including in Tower Paddle Boards, Nuts 'N More, SAT prep company Prep Expert and skincare company Simple Sugars, according to Nasdaq.
In his farewell, Cuban looked back on his time on the show fondly.
"I've learned so much from all of you," Cuban said to Barbara Corcoran, Greiner, Herjavec, John and O'Leary in his farewell episode. "And to 'Shark Tank,' The people who supported us, to the people who love us. I love you guys like family."
Mark Cuban says farewell to 'Shark Tank'; How Kevin O'Leary, other sharks toasted him
Why is Mark Cuban leaving 'Shark Tank'?
Cuban cited family as his official reason for leaving the show. Cuban and wife Tiffany Stewart share three children: daughters Alexis and Alyssa and son Jake.
"My kids are teenagers, and I want to spend more time with them," Cuban told People magazine in October. He pointed to the family-conflicting two-week shooting schedule in June and September as the deal-breaker. "When they were young, it was like, 'OK, we're going to wait for Dad.' Now that they're teenagers, they aren't waiting for Dad at all, and in September, they've just gotten back to school. I want to be there for that."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Stifel Nicolaus Sticks to Their Buy Rating for Alkermes (ALKS)
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Alkermes (ALKS – Research Report), with a price target of $42.00. The company's shares closed last Friday at $29.09. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Matteis is a 3-star analyst with an average return of 1.2% and a 41.20% success rate. Matteis covers the Healthcare sector, focusing on stocks such as Alkermes, Neurocrine, and uniQure. In addition to Stifel Nicolaus, Alkermes also received a Buy from UBS's Ashwani Verma in a report issued on June 17. However, on June 10, RBC Capital maintained a Hold rating on Alkermes (NASDAQ: ALKS).
Business Insider
2 hours ago
- Business Insider
Ventyx Biosciences (VTYX) Gets a Hold from Stifel Nicolaus
In a report released today, from Stifel Nicolaus maintained a Hold rating on Ventyx Biosciences (VTYX – Research Report), with a price target of $2.00. The company's shares closed last Friday at $2.26. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter In addition to Stifel Nicolaus, Ventyx Biosciences also received a Hold from Morgan Stanley's Vikram Purohit in a report issued on June 17. However, on June 18, Wells Fargo maintained a Buy rating on Ventyx Biosciences (NASDAQ: VTYX). VTYX market cap is currently $160.8M and has a P/E ratio of -1.29.
CNBC
3 hours ago
- CNBC
Bitcoin sinks below $99,000 as U.S. strikes on Iran trigger crypto market sell-off
Bitcoin fell to its lowest level since May over the weekend, as rising tensions in the Middle East and renewed inflation fears triggered a sharp selloff across digital assets. Bitcoin dropped below the $99,000 mark on Sunday — its lowest point in more than a month — as the crypto market became the first to react to escalating geopolitical risk. Bitcoin is trading around $99,380, down more than 2% over the past 24 hours, while ether has dropped 5% to below $2,200. Solana, XRP, and dogecoin also posted sharp losses, dragging the entire crypto complex deep into the red. The selloff appears to be a combination of geopolitical shock and macroeconomic concern. Iran has reportedly threatened to block the Strait of Hormuz — a vital shipping lane that handles about 20% of global oil supply. JPMorgan warns that a full closure could drive oil prices as high as $130 per barrel. One prominent macro research firm notes that such a spike could send U.S. inflation back toward 5% — a level not seen since March 2023, when the Fed was still actively raising rates. That outlook has traders reassessing the path of interest rates — and rotating out of speculative assets like crypto. While bitcoin is often pitched as an inflation hedge, it's currently behaving more like a high-beta tech stock. According to crypto data provider Kaiko, bitcoin's correlation with the tech-heavy Nasdaq has climbed sharply in recent weeks, after hitting a multi-month low earlier this year — a period that coincided with surging inflows into spot bitcoin ETFs. Institutional positioning also appears to have shifted. More than $1.04 billion flowed into spot bitcoin ETFs from Monday through Wednesday last week, according to data from CoinGlass. But those inflows collapsed heading into the weekend, with zero net movement Thursday and just $6.4 million on Friday — coinciding with President Donald Trump's early G7 departure and the announcement of a two-week review of U.S. options on Iran. The technical breakdown added fuel to the selloff. CoinGlass research shows bitcoin's drop below $99,000 triggered forced selling across offshore derivatives platforms like Binance and Bybit. At its peak on Sunday, more than $1 billion in crypto positions were liquidated during a 24-hour span — with over 95% coming from long bets, underscoring just how overexposed the market was heading into the weekend.
